Oncimmune

November 27, 2019

Veracyte’s nasal lung cancer test results raise questions

Amid the sea of lung cancer blood test developers, one company has nosed out a different approach.

September 09, 2019

World Lung 2019 – Oncimmune’s liquid biopsy hits in large trial

The data are positive, but might not do much for the company’s sales.

April 25, 2019

Deals and data in the offing for Oncimmune

Oncimmune is not the only company looking to use the immune system to diagnose cancer. But its growth plans are intense, and it intends to prove the economic benefits of…

January 19, 2017

Medtechs flock to London as 2016 sees biggest IPO ever

October 21, 2016

Oncimmune

Veracyte’s nasal lung cancer test results raise questions

World Lung 2019 – Oncimmune’s liquid biopsy hits in large trial

Deals and data in the offing for Oncimmune

Medtechs flock to London as 2016 sees biggest IPO ever

Irhythm rocks the Nasdaq

Latest Reports

Evaluate Vantage COVID-19 Report

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

Editor's Picks

Covid-19 antibody tests face a very specific problem

Covid-19’s clinical damage starts to emerge

The crucial data readouts coming soon for small biotechs

AACR 2020 preview – no Tigit, but plenty of novel mechanisms

The long path to an effective coronavirus vaccine